Title : Humoral Compensation after Bortezomib Treatment of Allosensitized Recipients.

Pub. Date : 2017 Jul

PMID : 28232617






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bortezomib treatment given intravenously twice weekly for 1 month (1.3 mg/m2 per dose) clearly reduced the numbers of antibody-producing cells and CD38+CD19+CD20- plasma cells in the bone marrow (P<0.05), but donor-specific alloantibody levels did not decrease. Bortezomib keratin 20 Homo sapiens